Form 4 for BIVI BIOVIE INC.
Accepted 2021-09-29 00:00:00 ET · period of report 2020-01-02 · accession 0001520138-21-000592 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-09-29 | 2020-01-02 | BIVI | BERMAN RICHARD J | Dir | A - Grant | $0.00 | +1,600 | 1,600 | New | $0 |
| DM | 2021-09-29 | 2020-01-19+ | BIVI | BERMAN RICHARD J | Dir | A - Grant | $0.00 | +103.3K | 102.5K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2020-01-02 | A | A | 1,600 | $0.00 | 1,600 | D | — | — | |
| 2 | Derivative | Stock Option (right to buy) | 2020-01-19 | A | A | 800 | $0.00 | 800 | D | $2.80 · 2020-01-19 to 2025-01-19 | 800 Common Stock | |
| 3 | Derivative | Stock Option (right to buy) | 2020-12-18 | A | A | 102,500 | $0.00 | 102,500 | D | $13.91 · — to 2025-12-18 | 102,500 Common Stock | (F1) This option was 25% vested upon grant, with an additional 25% on each of the first three anniversaries of the grant. |